Cutler Group LP Infinity Pharmaceuticals, Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$0.59 - $1.7 $118 - $340	-200 Reduced 50.0%	200 $0
Q2 2022 Aug 04, 2022	SELL	$0.49 - $1.2 $5,381 - $13,178	-10,982 Reduced 96.49%	400 $0
Q1 2022 Apr 14, 2022	BUY	$0.85 - $2.4 $1,785 - $5,040	2,100 Added 22.62%	11,382 $12,000
Q4 2021 Jan 18, 2022	BUY	$1.86 - $3.36 $16,892 - $30,515	9,082 Added 4541.0%	9,282 $20,000
Q3 2021 Oct 26, 2021	BUY	$1.52 - $3.82 $304 - $764	200 New	200 $0
Q1 2019 May 10, 2019	SELL	$1.18 - $1.91 $118 - $191	-100 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$1.8 - $2.74 $180 - $274	100 New	100 $0

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.